CVS Health Financials

Market Capitalization $84.25 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	15.89
Forward PE	10.28
Price to Sales TTM	$0.22
Price to Book MRQ	$1.09
Enterprise to Revenue	0.41
Enterprise to EBITDA	11.19

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	1.40%
Operating Margin	3.50%
Return on Assets TTM	2.31%
Return on Equity TTM	6.93%

Income Statement

Revenue TTM	$376,741,003,264
Revenue per Share TTM	$299.18
Quarterly Revenue Growth	6.90%
Gross Profit TTM	$51,016,998,912
EBITDA	$15,613,000,000
Net Income to Common TTM	$5,280,000,000
Diluted EPS TTM	$4.19
Quarterly Earnings Growth YoY	59.80%

Balance Sheet

Total Cash MRQ	$12,654,000,128
Total Cash per Share MRQ	$10.00
Total Debt MRQ	$
Total Debt to Equity MRQ	105.32
Current Ratio MRQ	0.82
Book Value per Share MRQ	$60.96

Cash Flow

Operating Cash Flow TTM	$8,760,000,512
Levered Free Cash Flow TTM	$6,530,874,880

CVS Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	1,260,000,000
Float Shares	1,262,400,839
Avg 10 Volume	7,694,575
Avg 30 Volume	None
Shares Short	18,713,654
Short Ratio	2.22
Short % of Shares	1.50%
% Held by Insiders	1.07%
% Held by Institutions	87.36%

Stock Price Summary

Beta	0.56
Fifty Two Week Low	$43.56
Fifty Two Week High	$72.51
Fifty Two Week Change	16.03%
Day 50 MA	$65.08
Day 200 MA	$60.40

Dividends and Splits

Forward Annual Dividend Rate	$2.66
Forward Annual Dividend Yield	3.94%
Trailing Annual Dividend Rate	$2.66
Trailing Annual Dividend Yield	3.94%
Payout Ratio	63.48%
Dividend Date	2025-05-01
Ex Dividend Date	2025-04-22
Last Split Factor
Last Split Date	2005-06-07